or
forgot password

    • cancer clinical trials in bartlesville, OK

    • Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Renal Cell Carcinoma
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Human Immunodeficiency Virus
    Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Advanced Breast Cancer, Breast Cancer
    Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Breast Cancer
    Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Breast Cancer, Advanced Breast Cancer
    ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Non-Small Cell Lung Cancer (NSCLC)
    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Carcinoma, Renal Cell, Kidney Neoplasms
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Carcinoma, Renal Cell
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Colorectal Neoplasms
    Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Carcinoma, Renal Cell
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Osteoporosis
    Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Carcinoma, Non-Small-Cell Lung
    Expanded Access Program for Maraviroc At Multiple Centers
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Advanced HIV Infection
    A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Breast Neoplasms
    A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Neoplasms
    A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Carcinoma, Non-Small Cell Lung
    Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung
    Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Colorectal Neoplasms
    Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer
    Pfizer Investigational Site
    Bartlesville, Oklahoma 74006
    Carcinoma, Large Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Adenosquamous Cell